利用MTT法检测多糖对大鼠肾系膜细胞增殖的影响。
MTT assay was used to study the effect of polysaccharides on rat glomerular mesangial cells.
目的：探讨肝X受体在肾系膜细胞脂质代谢中的作用及机制。
Objective: To examine the role of liver X receptors (LXRs) in lipid metabolism in cultured mouse mesangial cells.
肾系膜细胞培养基是专门为正常人类肾系膜细胞体外培养设计的最适于其生长的培养基。
Mesangial cell medium (MsCM) is a complete medium designed for optimal growth of normal human renal mesangial cells in vitro.
目的：探讨肾疏宁防治系膜基质硬化的细胞分子机制。
Objective: To study the cellular and molecular mechanism of Shenshuning (SSN) in preventing mesangial sclerosis.
本实验用小鼠前胃癌细胞（FC）移植于615近交系小鼠肾被膜囊下，观察其侵袭过程的形态学改变。
Transplantable mouse forestomach carcinoma (FC) was used in this experiment. Tumor fragments were transplanted in the subrenal capsule of the syngenic 615line mouse.
目的：探讨中药肾康注射液对脂多糖诱导肾小球系膜细胞增殖的影响。
Objective: To study the effect of Shenkang injection on the proliferation of human mesangial cell induced by LPS.
结论护肾固精方治疗系膜增殖性肾炎等肾小球疾病的作用机理之一，可能与抑制MC增殖和促其细胞凋亡有关。
Conclusion One of action mechanism of HSGJF treating mesangial proliferative nephritis and other renal glomerular diseases is to inhibit MC proliferation and promote apoptosis.
目的探讨“延肾胶囊”对残肾肾小球系膜细胞凋亡及其细胞外基质代谢的影响。
Objective To elucidate the effect of Yan-Shen Capsule on glomerular mesangial cell apoptosis and extracellular matrix metabolism of remnant kidney.
结论：HGF通过促进系膜细胞表达LDL受体，增加系膜细胞对LDL的摄取，可能参与了脂质肾损伤过程。
Conclusion: HGF can up-regulate expression of LDL receptor in mesangial cells and increase mesangial cells uptake of LDL, so HGF may play a role in lipid-induced kidney injury.
目的：探讨肾康注射液与苯那普利对人肾小球系膜细胞（MC）增殖的不同抑制作用强度。
To explore the intensity of inhibitory function of Shenkang injection (SKI), a Chinese herbal recipe, and benazepril on the proliferation of human glomerular mesangial cell (MC).
肾血宁胶囊能抑制肾小球系膜细胞的增殖，并通过下调FN在肾内的表达，抑制肾小球细胞外基质的积聚；
Shen-Xue-Ning capsule can inhibit mesentery cell hyperplasia and extracellular matrix collection of glomerular by regulating FN in kidney;
方法：以健康志愿者服用保肾片，取不同浓度含药人血清加入系膜细胞培养体系中。
Methods: Human serum from healthy volunteers with different concentrations in presence or absence of BST were added to HMCs.
方法：以健康志愿者服用保肾片，取不同浓度含药人血清加入系膜细胞培养体系中。
Methods: Human serum from healthy volunteers with different concentrations in presence or absence of BST were added to HMCs.
应用推荐